Outperform Recommendation Issued On GPCR By BMO Capital

March 17, 2026 12:15:09 pm

Source: KlickAnalytics

2026-03-17 12:15:09 ET

BMO Capital analyst issues OUTPERFORM recommendation for GPCR on March 17, 2026 12:29PM ET.

The previous analyst recommendation was Outperform.

GPCR was trading at $56.6529 at issue of the analyst recommendation.

The overall analyst consensus : BUY.

Current analyst recommendations are : 14 - Buy recommendations .

Latest 10 recommendations < ...
Full story available on KlickAnalytics.com

Structure Therapeutics Inc.

-1.68% G/L:

$45.5399 Last:

456,970 Volume:

$46.04 Open:

March 22, 2026 04:26:16 pm

March 17, 2026 12:15:09 pm

March 16, 2026 02:15:03 pm

March 16, 2026 07:00:00 am

Market Cap $5,430,883,453

Float 65,267,397

Insiders Ownership 0.07%

Institutions 67

Short Percent N/A

Industry Biotechnology & Life Sciences

Sector Healthcare

Website www.structuretx.com

Country US

City South San Francisco